Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy
A systematic review specifically examining tirzepatide found no significantly increased risk of pancreatitis compared to control groups including placebo, basal insulin, and selective GLP-1 receptor agonists
Regulation of muscle mass by growth hormone and IGF-I
It works by: Slowing how quickly your stomach empties Reducing appetite and cravings Encouraging better portion control Supporting insulin when sugar is present Improving how your body burns and stores energy GLP-1 is not insulin
Although a direct comparison of high-dose oral allulose with injectable GLP-1 drugs remains to be done, the preliminary data suggests that adding allulose to your diet (or better yet including it in food products that are easily integrated into any diet) may provide a more natural alternative to achieving long-term weight loss than to use of chemically modified hormones (i.e., GLP-1 drugs) with their significant side effects
On the first day, the medication begins to affect the brain and digestive system, but its full appetite-suppressing effects unfold gradually as the body adjusts to the medication
